Search clinical trials for: BI 891065

Total 1286 results

Boehringer Ingelheim

Completed

Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo

Alzheimer Disease

United States, Spain, Canada, United Kingdom, Germany, Italy, Netherlands, Portugal, Austria, Belgium, France, Poland
Boehringer Ingelheim

Completed

A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

This Study in Healthy Men and Women Tests Whether BI 409306 Has an Effect on the ECG (Thorough QT Study)

Healthy

Germany
Boehringer Ingelheim

Active, not recruiting

A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation

Solid Tumors, KRAS Mutation

Spain, United Kingdom, United States, Belgium
Beijing Tiantan Hospital

Completed

Treatment of Acute Ischemic STroke With Edaravone Dexborneol II (TASTE-2)

Acute Ischemic Stroke | Mechanical Thrombectomy | Edaravone Dexborneol | Phase III

China
Boehringer Ingelheim

Completed

BI 671800 ED in Steroid-naive Asthmatic Patients

Asthma

United States, Australia, Canada, Colombia, Korea, Republic of, Mexico, New Zealand, Peru, Philippines, Taiwan
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Terminated

This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year

Psychotic Disorders

United States, Canada, United Kingdom, China
Boehringer Ingelheim

Completed

Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone

Hepatitis C

United States
Boehringer Ingelheim

Completed

A Study in People With Depression to Test the Effects of BI 1358894 on Parts of the Brain That Are Involved in Emotions

Depressive Disorder, Major

Germany
Boehringer Ingelheim

Active, not recruiting

A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)

Solid Tumors, KRAS Mutation; SOS1

United States, Netherlands, Germany
Ankara City Hospital Bilkent

Completed

Efficacy of Bi-level ESPB Application in Patients Undergoing VATS

Pain, Postoperative | Erector Spinae Plane Block | Thoracic Surgery, Video-Assisted | Multimodal Analgesia

Turkey
Biotronik SE & Co. KG

Recruiting

Post-market Clinical Follow-up Data Collection From Procedures With BIOTRONIK EP Products (BIO|COLLECT-EP)

Cardiac Arrhythmia

Germany
AbbVie
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male Volunteers

Healthy

Japan, Korea, Republic of
Boehringer Ingelheim

Completed

Bioavailability of BI 1356 and Glyburide in Healthy Male and Female Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female Volunteers

Healthy
Suez Canal University
National Research Centre, Egypt

Completed

Outcome of Preserved Mitral Valve Apparatus During Mitral Valve Replacement (EarlyOutcome)

Mitral Valve Replacement | Diseases of Mitral Valves | Abnormality of Mitral Valve Annulus (Disorder)

Egypt
Boehringer Ingelheim

Completed

Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses and Multiple Rising Oral Doses of BI 1356 BS in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Safety Tolerability and Pharmacokinetic of BI 409306

Healthy

Germany
Rigshospitalet, Denmark
Zimmer Biomet; University Hospital, Gentofte, Copenhagen

Unknown

Evaluation of Stability of Two Uncemented Hip Implants Used for Total Hip Arthroplasty

Osteoarthritis, Hip

Denmark
Xiangya Hospital of Central South University
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke (EARLYS)

Ischemic Stroke, Acute | Treatment Outcome

China
Boehringer Ingelheim

Completed

A Study to Test How Well Different Doses of BI 1356225 Are Tolerated by Men and Women With Obesity or Overweight

Obesity

Germany
University of Oxford
University of Copenhagen; Zimmer Biomet

Unknown

All Ligaments Left In Knee Arthroplasty Trial (ALLIKAT)

Primary Osteoarthritis of Knee Nos

United Kingdom
Boehringer Ingelheim

Terminated

BI 695500 vs Rituxan First Line Treatment in Patients With Low Tumor Burden Follicular Lymphoma

Lymphoma, Non-Hodgkin

Austria, Belgium, United States, Bulgaria, Croatia, Czech Republic
Boehringer Ingelheim

Completed

A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)

Leukemia, Myeloid, Acute

United States, Spain, Germany, Italy
Keming Gao
University of Michigan; Case Western Reserve University; University of Toledo...

Completed

Project Guard: Reducing Alcohol Misuse/Abuse in the National Guard

Alcohol Use

United States
Chinese University of Hong Kong

Completed

Herbal Treatment for Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

Hong Kong
Moi University
Indiana University

Not yet recruiting

Feasibility of Peer-mentor Delivered Substance Use Brief Intervention for Adolescents in Kenya

Substance Use

Kenya
Linnaeus University
Karolinska Institutet; Capio Group; The Kamprad Family Foundation for Entrepreneurship... and other collaborators

Recruiting

Implementation and Evaluation of Primary Care Behavioral Health in Sweden (KAIROS)

Mental Health Disorder | Psychological Distress | Life Style Induced Illness | Life Stress

Sweden
West China Hospital

Unknown

Trial of Monthly Versus Bi-weekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding

Esophageal and Gastric Varices

China
Hospital Israelita Albert Einstein

Completed

H-Senses Project - Self Care Mediated by the Senses

Stress

Brazil
Boehringer Ingelheim

Recruiting

DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With Topotecan

Small Cell Lung Carcinoma (SCLC)

United Kingdom, Germany, France, Poland
Kocaeli University

Completed

Comparison of Bi-level Erector Spine Plane Block and Combined Pectoral I-II Block in Breast Surgery

Postoperative Pain | Analgesia

Turkey
Astellas Pharma Inc

Completed

A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation

Chronic Constipation

Japan
Boehringer Ingelheim

Completed

Effect of Repeated Doses of BI 1060469 and BI 1021958 on Glomerular Filtration Rate (GFR) in Healthy Volunteers

Healthy

Germany
Ludwig Institute for Cancer Research
Boehringer Ingelheim; MedImmune LLC; PharmaJet, Inc.; CureVac; Cancer Research Institute...

Completed

Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC

NSCLC | Metastatic Non-small Cell Lung Cancer

United States
Massachusetts General Hospital
Boston University

Completed

The Summer Camp Study: Blood Glucose Control With a Bi-Hormonal Bionic Endocrine Pancreas

Type 1 Diabetes

United States
Centro Universitário Univates

Completed

Effect of the Consumption of a Cheese Enriched With Probiotic Organisms in Improving Symptoms of Constipation

Constipation

Brazil
Boehringer Ingelheim

Completed

A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men

Healthy

Germany
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS Administered to Healthy Male Subjects

Healthy
BioInvent International AB
Merck Sharp & Dohme LLC

Recruiting

BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors

Hepatocellular Carcinoma | Non Small Cell Lung Cancer | Solid Tumors

Spain, Denmark, Poland, Sweden
BioInvent International AB

Recruiting

A Study of BI-1206 in Combination With Rituximab in Subjects With Indolent B-Cell Non-Hodgkin Lymphoma

Indolent B-Cell Non-Hodgkin Lymphoma

Spain, United States, Brazil, Sweden, Germany, Poland
Mirati Therapeutics Inc.
Boehringer Ingelheim

Completed

Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)

Metastatic Cancer | Advanced Cancer | Malignant Neoplasm of Colon | Malignant Neoplasm of Lung | Malignant Neoplastic Disease

United States
Haukeland University Hospital

Completed

Hypertonic Saline-hetastarch in Cardiac Surgery (HH)

Postoperative Cardiorespiratory Failure

Norway
Universidade Metodista de Piracicaba
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

Completed

Influence of Different Physical Therapy Resources Application After Reduction Stomach Surgery

Respiratory Tract Diseases | Pulmonary Atelectasis | Pathological Conditions, Signs and Symptoms

Brazil
Boehringer Ingelheim

Terminated

A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

Healthy

Germany
Gradalis, Inc.
Roche-Genentech

Completed

A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers

Cervical Cancer | Ovarian Cancer | Uterine Cancer | Advanced Gynecological Cancers

United States
University of Alabama at Birmingham
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Recruiting

Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA (TALC)

Hiv | Alcohol Problem

United States
University of Michigan
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Prevention Interventions for Opioid Misuse

Opioid Use

United States

Search clinical trials for: BI 891065

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations